← Back to all signals
RESEARCH PAPER ANALYSIS

Does motherhood increase the risk of developing subsequent malignant neoplasms after childhood cancer treatment?

AI interpretation is pending for this paper.

Open original publication →
PMID41691744
JournalCancer epidemiology
Publication Date2026-02-14
Ingested2026-08-02 12:06 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: Most young women who have survived childhood cancer express a desire to have children. Many of them are concerned about the potential adverse impact of pregnancy on their health, which has been affected by prior cancer treatment. The aim of this study was to determine whether motherhood increases the risk of developing subsequent malignant neoplasms. METHODS: The study cohort consisted of 942 female childhood cancer survivors, median age at first cancer diagnosis 10.84 years (IQR 4.29-14.92), who had been treated at the Department of Pediatric Hematology and Oncology, Motol University Hospital, Prague, between 1965 and 2018. In this group, 363 women gave birth to 559 children. RESULTS: Seventy-three female childhood cancer survivors developed 80 subsequent malignant neoplasms. Of these, 40 subsequent malignant neoplasms occurred in women who had children. The median time from the end of primary cancer treatment to first subsequent malignant neoplasm development was 19.93 years (IQR 14.55-26.56). A comprehensive analysis revealed no difference in the risk of subsequent malignant neoplasms between mothers and "non-mothers". Only older age of the cancer survivors in follow-up and previous radiotherapy (p = 0.0133) were significant risk factors for subsequent malignant neoplasm development. CONCLUSIONS: This study revealed that motherhood does not increase the risk of subsequent malignant neoplasms. We confirmed a statistically significant increased risk of subsequent malignant neoplasms only for previous treatment modality, the length of follow-up and the age of the female childhood cancer survivors. These results are important for improving the quality of life of young cured women who are worried about a planned pregnancy. PLAIN LANGUAGE SUMMARY: This study evaluated the long-term cancer risk among women treated for cancer during childhood, with particular focus on those who later gave birth. Among 942 participants, 363 had post-treatment pregnancies. Results indicate that childbearing does not increase the risk of subsequent malignant neoplasms in this population. Instead, elevated risk for subsequent malignant neoplasms was associated with older age at follow-up and prior exposure to radiotherapy. These findings provide evidence that pregnancy is safe for female childhood cancer survivors and support informed reproductive decision-making.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Pediatric Acute Leukemias: Epidemiological, Clinical Features, and Diagnostic Contribution of Flow Cytometry in a Resource-Limited Setting. Cureus 61.5 2 Patient Care of Pregnant Women With Chronic Myeloid Leukemia in a Resource Limited Setting-Case Reports From Ghana. Case reports in hematology 63.8 3 Porto-sinusoidal vascular disorder and sinusoidal obstructive syndrome in patients treated with thiopurines: a systematic review. Annals of hepatology 75.1 4 Palbociclib in combination with dexamethasone, bortezomib, and doxorubicin for pediatric relapsed acute lymphoblastic leukemia. Blood neoplasia 49.12 5 Plasma Cell Gingivitis With Cheilitis in an Adolescent: A Case Report. Cureus 51.1 6 Efgartigimod as a salvage therapy for anti-NMDAR encephalitis patients after first-line treatment failure: a case series. Frontiers in neurology 65.18 7 Successful treatment of refractory classic juvenile pityriasis rubra pilaris with adalimumab in a 4-year-old girl: a case report. Frontiers in immunology 67.0 8 Clinical spectrum and survival outcomes of malignancies in pediatric patients with inborn errors of immunity. Frontiers in immunology 65.82 9 Therapy-related acute myeloid leukemia with 24-month latency after CD19 CAR-T cell therapy in relapsed/refractory diffuse large B-cell lymphoma: a case report. Frontiers in medicine 63.86 10 HPV52 predominates in cervical infections and precancerous lesions in Chongqing, China: a 6-year study linking genotypes to vaginal microecology. Frontiers in public health 61.9 11 Report from the National Pediatric Cancer Foundation - infantile glioma and other non-embryonal central nervous system tumors: evolving molecular advances and current treatment landscape. Frontiers in oncology 68.34 12 Targeted immunotherapies for anaplastic lymphoma kinase-positive pediatric tumors: current advances and future perspectives. Frontiers in immunology 87.5 13 The real-world practice of fertility preservation for patients with epithelial ovarian cancer in Asian regions. Journal of gynecologic oncology 67.2 14 Multiple congenital dermal sinus tracts: a case-based review involving a unique triple-tract configuration that challenges current embryological concepts. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 49.9 15 Natural products mediate ferroptosis and immune microenvironment-linked sensitization in osteosarcoma: from chemotherapy resistance to combined therapeutic transformation. Molecular diversity 71.38 16 Age-associated epigenomic heterogeneity in papillary tumors of the pineal region: a multicenter YoungNOA investigation. Acta neuropathologica communications 66.6 17 Pediatrics supratentorial intraventricular atypical teratoid/rhabdoid tumors: a case report and a systematic review of the literature. European journal of pediatrics 77.1 18 Cranial pathologies in Noonan syndrome: clinical implications for pre-growth hormone neuroimaging. European journal of pediatrics 61.4 19 Narciclasine reduces proliferation and migration of neuroblastoma cells and decreases FAK/PI3K pathway activation. Medical oncology (Northwood, London, England) 43.0 20 Balancing safe resection and spinal stability in osteoblastoma and osteoid osteoma: a retrospective study. European journal of orthopaedic surgery & traumatology : orthopedie traumatologie 67.4 21 Scaling up symptom screening for routine use in pediatric oncology: provincial implementation. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 61.6 22 Extent of resection and craniopharyngioma recurrence: a volumetric analysis. Journal of neuro-oncology 66.1 23 Fertility in breast cancer survivorship: a scoping review. Journal of cancer survivorship : research and practice 81.0 24 Clinical practice guideline for psoriasis management in Latin America. Anais brasileiros de dermatologia 76.5 25 Constrained Choices and Meaning-Making: A Qualitative Study of Caregivers of Children With Hematologic Malignancies. Psycho-oncology 59.6 26 Timely Surgical Approaches for Pediatric Epilepsy Resistant to Medication. Journal of surgery and research 64.0 27 The Journey with paediatric cancer: reflections on its impact on patients and their families. The Pan African medical journal 56.0 28 Pars plana vitrectomy in uveitis of diverse etiologies: indications and surgical outcomes. BMC ophthalmology 63.5 29 Persistent Oropharyngeal Hemangioma Causing Progressive Upper Airway Compromise: Diagnostic and Therapeutic Challenges. Cureus 61.64 30 Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment, and follow-up of patients with hepatocellular carcinoma. ESMO open 71.84 31 Life Saving Hepatic Resections in Ruptured Pediatric Hepatoblastoma - a Report of 3 Cases. Indian journal of surgical oncology 63.6 32 Development and Internal Validation of the SPR-HCC Score System: A Prognostic Tool for Survival Prediction in Hepatocellular Carcinoma in a Resource-Limited Setting. Asian Pacific journal of cancer prevention : APJCP 72.02
PATIENT-FRIENDLY SUMMARY

Does motherhood increase the risk of developing subsequent malignant neoplasms after childhood cancer treatment?

For education only—not personal medical advice.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic